Milestone Achieved as Immunotherapeutic Agent Under Investigation for the Treatment of Ovarian Cancer Added to Asset PortfolioTAMPA, Fla., Sept. 08, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB ...

Cyte-09 Chassis Blueprint: Höllvanian Pitchweave Fragment x200, Experimental Arc-Relay x6, Techrot Motherboard x8, Alloy Plate x1000, and 15000 Credits. It takes 12 hours (real time) to be completed.

Michael Yurkowsky, Chief Executive Officer for H-CYTE, stated, “I’m pleased to announce our entry into a letter of intent to acquire Catheter Precision, Inc. David Jenkins and his team have ...

Shares of H-CYTE, Inc. (OTCMKTS:HCYTD – Get Free Report) traded down 49.5% on Tuesday .The company traded as low as $2.02 and last traded at $2.02. 400 shares changed hands during mid-day ...

--H-CYTE Inc. the owner and operator of innovative medical technology products and services including LungCYTE and Lung Health Institute, announces it has raised $6 million in new funding.

TAMPA, Fla., Sept. 29, 2020 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a developer of regenerative cellular therapeutics, announced today that Robert Greif has been named the company’s new ...